Table 1.
Characteristic | Total Respondents (N=303) | Total Non-Respondents (N=145) | P-value, chi-squared test, respondents vs. non-respondents |
---|---|---|---|
Provider gender, % (n) | |||
Female | 64 (195) | 66 (96) | 0.70 |
Male | 36 (108) | 34 (49) | |
Mean (SD) provider age in years | 53.0 (10.4) | 51.8 (10.9) | 0.24* |
Practice setting, % (n) | |||
Private practice | 79 (240) | 81 (117) | |
Hospital or clinic | 17 (52) | 15 (22) | |
HMO | 4 (11) | 4 (6) | 0.85 |
Practice location, % (n) | |||
Rural/Suburban | 49 (147) | 43 (62) | 0.25 |
Urban | 52 (156) | 57 (83) | |
Practice region, % (n) | |||
South | 34 (104) | 44 (64) | |
Midwest | 23 (70) | 18 (26) | |
West | 19 (58) | 23 (34) | |
Northeast | 23 (71) | 15 (21) | 0.04 |
Practice-level decision-making about vaccines, % (n) | |||
Larger System Level | 29 (86) | 31 (44) | |
Independent | 71 (208) | 69 (99) | 0.74 |
Median (IQR) number of providers in practice | 6.0 (3.5–9.0) | 5.0 (3.0–10.5) | 0.74† |
Proportion of privately insured patients in practice, % (n) | |||
0–24 | 24 (72) | N/A | |
25–49 | 23 (48) | N/A | |
≥50 | 53 (159) | N/A | |
Proportion of Medicaid or your state’s Children’s Health Insurance patients in practice, % (n) | |||
0–24 | 40 (117) | N/A | |
25–49 | 27 (79) | N/A | |
≥50 | 33 (97) | N/A | |
Patient race/ethnicity in practice, % (n) | |||
≥10% Black/African American | 58 (171) | N/A | |
≥10% Hispanic | 55 (164) | N/A | |
≥10% Asian/Pacific Islander | 32 (96) | N/A |
IQR: interquartile range; SD: standard deviation.
t-test,
Fisher’s Exact test,
Wilcoxon Test